Sex Hormones, Postoperative Pain and Opioid Use
SPO
Relationship Between Sex Hormones, Postoperative Pain and Opioid Use: the Role of Immune Factors
1 other identifier
observational
210
1 country
1
Brief Summary
Aim 1- To identify relationships between sex hormone levels and postoperative pain and opioid use. Aim 2: To determine whether the effects of testosterone on postoperative pain and opioid use are mediated by immune factors
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedFirst Posted
Study publicly available on registry
September 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2029
August 13, 2025
August 1, 2025
3.8 years
August 28, 2023
August 12, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Sex hormone level of Testosterone
Baseline
Sex hormone level of estrogen
Baseline
Sex hormone level of progesterone
Baseline
Levels of IL-10 and IL-6
Immune factors
Baseline
Study Arms (1)
Postoperative patients
Pediatric female patients undergoing a surgical procedure
Interventions
Eligibility Criteria
Pediatric female patients between the ages 11-16 undergoing an orthopedic surgical procedure
You may qualify if:
- Pediatric female patients between the ages 11-16 undergoing an orthopedic (trauma and non-trauma) surgical procedure involving a long bone or joint, or the spine, English speaking
You may not qualify if:
- Pregnancy; Diagnosis of chronic pain, Psychiatric, developmental or neurological disorders, Disorders that are associated with pubertal maturation (e.g., precocious puberty).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University School of Medicine
St Louis, Missouri, 63110, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asst Prof of Anesthesiology
Study Record Dates
First Submitted
August 28, 2023
First Posted
September 5, 2023
Study Start
September 1, 2023
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2029
Last Updated
August 13, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share